CBU
RDHL

CIBC Bank USA’s Redhill Biopharma RDHL Stock Holding History

CIBC Bank USA’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$73K Hold
12
– – 0.01% 270
2019
Q3 		$84K Hold
12
– – 0.01% 265
2019
Q2 		$78K Hold
12
– – 0.01% 261
2019
Q1 		$100K Hold
12
– – 0.01% 245
2018
Q4 		$67K Hold
12
– – 0.01% 236
2018
Q3 		$106K Sell
12
-8
-40% -$65.2K 0.01% 252
2018
Q2 		$171K Hold
20
– – 0.02% 244
2018
Q1 		$103K Buy
20
+10
+100% +$57.6K 0.01% 256
2017
Q4 		$51K Buy
+10
New +$67.4K 0.01% 265

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return

CIBC Bank USA's RDHL Position: Q4 2019 in Review

CIBC Bank USA held its Redhill Biopharma (RDHL) position steady in Q4 2019 at 12 shares worth $73K. The position accounts for 0.01% of the portfolio, ranked #270.

CIBC Bank USA first reported a position in RDHL in Q4 2017 and has held it in 9 quarters since. The position peaked at $171K in Q2 2018. 42 funds tracked by Wall St. Rank hold RDHL as of Q4 2019.

  • CIBC Bank USA held 12 shares of Redhill Biopharma worth $73K as of Q4 2019.
  • CIBC Bank USA left its Redhill Biopharma share count unchanged in Q4 2019.
  • Redhill Biopharma made up 0.01% of CIBC Bank USA's portfolio in Q4 2019, its #270 holding.
  • CIBC Bank USA first reported a position in Redhill Biopharma in Q4 2017 and has held it in 9 quarters since.
  • CIBC Bank USA's Redhill Biopharma position peaked at $171K in Q2 2018.
  • 42 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2019.

Based on CIBC Bank USA's 13F filing for Q4 2019, filed 29 Jan 2020.